Top

Internal and Emergency Medicine

Published in:

01-11-2020 | SARS-CoV-2 | CE - LETTER TO THE EDITOR

COVID-19: in the uncertainty, do not try this at home

Authors: Tommaso Lupia, Silvia Corcione, Francesco Giuseppe De Rosa

Published in: Internal and Emergency Medicine | Issue 8/2020

Excerpt

Dear Editor, …

Li Q, Guan X, Wu P et al (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382(13):1199–1207. https://doi.org/10.1056/NEJMoa2001316CrossRefPubMedPubMedCentral

Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ (2020) Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.2009637117CrossRefPubMedPubMedCentral

Cao B, Wang Y, Wen D et al (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799. https://doi.org/10.1056/nejmoa2001282CrossRefPubMed

Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020) Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. https://doi.org/10.1016/s0140-6736(20)31180-6CrossRef

Day M (2020) Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 368:1086CrossRef

Title: COVID-19: in the uncertainty, do not try this at home
Authors: Tommaso Lupia
Silvia Corcione
Francesco Giuseppe De Rosa
Publication date: 01-11-2020
Publisher: Springer International Publishing
Keywords: SARS-CoV-2
Pneumonia
COVID-19
Published in: Internal and Emergency Medicine / Issue 8/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-020-02471-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Current treatment of COVID-19 in renal patients: hope or hype?

Derivation and validation of the clinical prediction model for COVID-19

Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action

Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients

Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort

Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials